Keep Your Active Eyes on Bristol-Myers Squibb Company (BMY)

Lloyd Doyle
April 16, 2018

Jennison Associates LLC now owns 26,854,242 shares of the biopharmaceutical company's stock worth $1,711,689,000 after purchasing an additional 3,735,453 shares during the period. The institutional investor held 254,589 shares of the technology company at the end of 2017Q4, valued at $44.93 million, up from 233,188 at the end of the previous reported quarter. When we look at the Volatility of the company, Week Volatility is at 1.50% whereas Month Volatility is at 1.85%. The last session's volume was 10,671,016 compared to its average daily volume of 7.93M shares. About 537,773 shares traded. Pinnacle Financial Partners, Inc. AT&T Inc. (NYSE:T) has declined 15.88% since April 16, 2017 and is downtrending. It has underperformed by 0.18% the S&P500. The Massachusetts-based Wilkins Investment Counsel Incorporated has invested 0.07% in Bristol-Myers Squibb Company (NYSE:BMY). Stocks Market Cap (SMC) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. The institutional investor owned 52,289 shares of the biopharmaceutical company's stock after purchasing an additional 11,889 shares during the period. Coastline Trust Co who had been investing in Bristol Myers Squibb Co for a number of months, seems to be bullish on the $91.04 billion market cap company. The stock decreased 0.32% or $0.19 during the last trading session, reaching $58.65. About 18.16 million shares traded or 141.40% up from the average.

TRADEMARK VIOLATION NOTICE: "Xact Kapitalforvaltning AB Has $18.87 Million Stake in Bristol-Myers Squibb (BMY)" was reported by The Lincolnian Online and is the property of of The Lincolnian Online. It has underperformed by 44.60% the S&P500. It also increased its holding in Nuvasive Inc (NASDAQ:NUVA) by 77,200 shares in the quarter, for a total of 260,200 shares, and has risen its stake in Laboratory Corp Amer Hldgs (NYSE:LH). Samuels Theodore R. II had bought 4,000 shares worth $249,187 on Friday, December 15. (NASDAQ:FB) for 41,300 shares. 750 shares were sold by Stretch Colin, worth $129,325 on Tuesday, October 24. (NASDAQ:PNFP) on Tuesday, March 6. (NASDAQ:FB) for 276,403 shares.

Investors sentiment decreased to 0.96 in Q4 2017. The Healthcare stock showed a change of -0.85% from opening and finally closed at $58.65 by scoring -0.32%.

As a potential investor, you will also want to being looking at earnings per share and whether or not is has sustained or grown. 102,208 were reported by Comerica Bancorporation. Lynch And Assoc In holds 0.36% or 15,748 shares. Baltimore accumulated 8,380 shares. Argent Cap Management Limited Liability Com has 256,373 shares for 0.55% of their portfolio. Grace & White New York accumulated 9,848 shares. (NASDAQ:FB). The Texas-based Visionary Asset Management has invested 0.07% in Facebook, Inc. (NASDAQ:PNFP). Assetmark, a California-based fund reported 33 shares. Cambridge has invested 0.26% in Medtronic plc (NYSE:MDT). Creative Planning accumulated 0% or 3,375 shares. (NYSE:CF). Nordea Mngmt Ab reported 8,130 shares stake. (NASDAQ:FB). Louisiana State Employees Retirement Sys has 1.16% invested in Facebook, Inc. These Revenue projections are a consensus of 4 Analysts. Apple Inc. had 393 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has "Outperform" rating by Leerink Swann on Monday, October 23. Stephens upgraded the shares of PNFP in report on Friday, January 29 to "Overweight" rating. The stock of CF Industries Holdings, Inc. (NASDAQ:FB) has "Buy" rating given on Thursday, November 2 by Mizuho. The firm has "Sector Perform" rating by Portales Partners given on Wednesday, July 22. (NASDAQ:FB) on Thursday, February 1 with "Hold" rating. The rating was maintained by Macquarie Research with "Buy" on Tuesday, September 1. HSBC has "Buy" rating and $4100 target. (NASDAQ:AAPL) rating on Wednesday, January 27. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and ten have given a buy rating to the stock. Therefore 45% are positive.

Bristol-Myers Squibb (NYSE:BMY) last issued its quarterly earnings results on Monday, February 5th. This simplified numeric scale spans the range of one to five which translates brokerage firm Buy/Sell/Hold recommendations into an average broker rating. Canandaigua Bancshares Tru holds 0.61% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 55,574 shares. The stock has "Neutral" rating by Hilliard Lyons on Monday, May 23. On Friday, October 27 the company was maintained by Credit Suisse.

Over the past 50 days, Bristol-Myers Squibb Company stock's -16.27% off of the high and 1.38% removed from the low. Stifel Nicolaus has "Buy" rating and $120 target.

Bristol-Myers Squibb Company (BMY) analysts on average have given a price target of $85.98 on BMY stock.

BMY opened at $59.42 on Monday.

Investors sentiment decreased to 0.94 in 2017 Q4. Its up 0.03, from 0.7 in 2017Q3. The ratio turned negative due to BMY positioning: 72 sold and 526 reduced. 147 funds opened positions while 670 raised stakes. Northern holds 0.38% or 24.21 million shares in its portfolio. D E Shaw & has 4.57 million shares. The company has Relative Strength Index (RSI 14) of 32.29 along with Average True Range (ATR 14) of 1.61. Bouchey Fincl Gp Ltd has 3,010 shares for 0.15% of their portfolio. Cwm Lc, a Nebraska-based fund reported 72,809 shares. Blume Capital Management Inc. raised its position in Bristol-Myers Squibb by 2.4% in the third quarter. Prentiss Smith And Com owns 2,333 shares. Tsp Cap Management Group reported 1.58% stake. Gam Hldgs Ag has invested 0.34% in Bristol-Myers Squibb Company (NYSE:BMY). Bristol-Myers Squibb's dividend payout ratio is 53.16%. 9,903 are owned by Paloma Prtn Mngmt Co. Chem Bank & Trust reported 39,902 shares stake.

Other reports by Iphone Fresh

Discuss This Article